{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:46Z","timestamp":1787004826726,"version":"build-2736575974"},"reference-count":120,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1053\/j.semdp.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T12:10:02Z","timestamp":1597061402000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["B-cell neoplasms and Hodgkin lymphoma in the spleen"],"prefix":"10.1053","volume":"38","author":[{"given":"Julia T","family":"Geyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0001","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajh.2830380205","article-title":"Primary non-Hodgkin lymphoma of the spleen","volume":"38","author":"Brox","year":"1991","journal-title":"Am J Hematol"},{"issue":"5\u20136","key":"10.1053\/j.semdp.2020.08.002_bib0002","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1081\/CNV-120002492","article-title":"Primary splenic lymphoma: report of 10 cases using the REAL classification","volume":"20","author":"Grosskreutz","year":"2002","journal-title":"Cancer Invest"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0003","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/PAS.0b013e318193fcef","article-title":"Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases","volume":"33","author":"Mollejo","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2020.08.002_bib0004","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1097-0142(197403)33:3<657::AID-CNCR2820330311>3.0.CO;2-D","article-title":"Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin\u2019s lymphomas","volume":"33","author":"Kim","year":"1974","journal-title":"Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2020.08.002_bib0005","first-page":"981","article-title":"Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas","volume":"61","author":"Goffinet","year":"1977","journal-title":"Cancer Treat Rep"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0006","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.hoc.2008.07.015","article-title":"Staging and evaluation of the patient with lymphoma","volume":"22","author":"Cheson","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"10.1053\/j.semdp.2020.08.002_bib0007","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study","volume":"127","author":"Barrington","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2020.08.002_bib0008","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/1097-0142(197106)27:6<1277::AID-CNCR2820270602>3.0.CO;2-T","article-title":"Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin\u2019s disease","volume":"27","author":"Kadin","year":"1971","journal-title":"Cancer"},{"issue":"15","key":"10.1053\/j.semdp.2020.08.002_bib0009","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM197304122881502","article-title":"Lymphocyte-depletion Hodgkin\u2019s disease. A clinicopathological entity","volume":"288","author":"Neiman","year":"1973","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/jclinpath-2015-203145","article-title":"EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma","volume":"68","author":"Parekh","year":"2015","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/1097-0142(19870101)59:1<99::AID-CNCR2820590122>3.0.CO;2-J","article-title":"Lymphocyte predominance Hodgkin\u2019s disease. A clinicopathologic reassessment","volume":"59","author":"Trudel","year":"1987","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2020.08.002_bib0012","first-page":"289","article-title":"Current problems in the histopathologic diagnosis and classification of Hodgkin\u2019s disease","volume":"2","author":"Neiman","year":"1978","journal-title":"Pathol Annu"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0013","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jcp.25.4.294","article-title":"The diagnosis of Hodgkin\u2019s disease in surgically excised spleens","volume":"25","author":"Farrer-Brown","year":"1972","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1972.18","article-title":"Sarcoid reactions and sarcoidosis in Hodgkin\u2019s disease and other malignant lymphomata","volume":"26","author":"Brincker","year":"1972","journal-title":"Br J Cancer"},{"issue":"16","key":"10.1053\/j.semdp.2020.08.002_bib0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJM197010152831609","article-title":"Isolated granulomas in Hodgkin\u2019s disease","volume":"283","author":"Kadin","year":"1970","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.002_bib0016","first-page":"518","article-title":"Incidence and importance of splenic sarcoid-like granulomas","volume":"101","author":"Neiman","year":"1977","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0017","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/1097-0142(197802)41:2<562::AID-CNCR2820410224>3.0.CO;2-X","article-title":"Epithelioid granulomas associated with Hodgkin\u2019s disease: clinical correlations in 55 previously untreated patients","volume":"41","author":"Sacks","year":"1978","journal-title":"Cancer"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0018","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/1097-0142(19800901)46:5<1240::AID-CNCR2820460526>3.0.CO;2-T","article-title":"Prognostic factors in pathological stage IIIA Hodgkin\u2019s disease","volume":"46","author":"Hoppe","year":"1980","journal-title":"Cancer"},{"issue":"26","key":"10.1053\/j.semdp.2020.08.002_bib0019","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0021","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00000478-199511000-00012","article-title":"Pathologic features of nodular lymphocyte predominance Hodgkin\u2019s disease in extranodal sites","volume":"19","author":"Chang","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2020.08.002_bib0022","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000478-200307000-00005","article-title":"Micronodular T-cell\/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis","volume":"27","author":"Dogan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0023","first-page":"18","article-title":"Non-Hodgkin\u2019s lymphoproliferative disorders involving the spleen","volume":"10","author":"Arber","year":"1997","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0024","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/1097-0142(19841015)54:8<1606::AID-CNCR2820540823>3.0.CO;2-5","article-title":"Primary splenic presentation of malignant lymphoma and related disorders. A study of 49 cases","volume":"54","author":"Kraemer","year":"1984","journal-title":"Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0025","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/1097-0142(197804)41:4<1440::AID-CNCR2820410432>3.0.CO;2-G","article-title":"Malignant lymphoma, small lymphocytic type: a clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma","volume":"41","author":"Evans","year":"1978","journal-title":"Cancer"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0026","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\"accelerated\" chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gine","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0027","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00000478-200205000-00008","article-title":"Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"26","author":"Asplund","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2020.08.002_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41379-019-0356-z","article-title":"Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis","volume":"33","author":"Liu","year":"2020","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0029","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/1097-0142(19811101)48:9<2047::AID-CNCR2820480922>3.0.CO;2-L","article-title":"Lymphocytic lymphoma simulating hairy cell leukemia: a consideration of reliable and unreliable diagnostic features","volume":"48","author":"Palutke","year":"1981","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1974.tb06769.x","article-title":"Prolymphocytic leukaemia","volume":"27","author":"Galton","year":"1974","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0031","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0889-8588(18)30498-2","article-title":"Prolymphocytic leukemia","volume":"4","author":"Stone","year":"1990","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0032","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/1097-0142(197811)42:5<2360::AID-CNCR2820420537>3.0.CO;2-1","article-title":"Prolymphocytic leukemia: clinical, histopathological, and cytochemical observations","volume":"42","author":"Bearman","year":"1978","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2020.08.002_bib0033","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.2004.04913.x","article-title":"B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia","volume":"125","author":"Ruchlemer","year":"2004","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1053\/j.semdp.2020.08.002_bib0034","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.leu.2404238","article-title":"IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)","volume":"20","author":"Del Giudice","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.semdp.2020.08.002_bib0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1309\/AJCPUBHM8U7ZFLOB","article-title":"Aberrations of MYC are a common event in B-cell prolymphocytic leukemia","volume":"142","author":"Flatley","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2020.08.002_bib0036","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V89.6.2015","article-title":"p53 abnormalities in B-cell prolymphocytic leukemia","volume":"89","author":"Lens","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s004280050423","article-title":"Composite\" lymphoma, lymphoplasmacytoid and diffuse large B-cell lymphoma of the spleen: molecular-genetic evidence of a common clonal origin","volume":"435","author":"Pescarmona","year":"1999","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0038","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0039","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.semdp.2020.08.002_bib0040","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","article-title":"MYD88 L265P mutation in Waldenstrom macroglobulinemia","volume":"121","author":"Poulain","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0041","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"New Engl J Med"},{"issue":"13","key":"10.1053\/j.semdp.2020.08.002_bib0042","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0043","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0044","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia","volume":"27","author":"Jimenez","year":"2013","journal-title":"Leukemia"},{"issue":"24","key":"10.1053\/j.semdp.2020.08.002_bib0045","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","article-title":"Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome","volume":"123","author":"Martinez-Trillos","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2020.08.002_bib0046","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0047","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0048","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0049","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.002_bib0050","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1053\/j.semdp.2020.08.002_bib0051","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2020.08.002_bib0052","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s004280000284","article-title":"Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome","volume":"437","author":"Molina","year":"2000","journal-title":"Virchows Arch"},{"issue":"20","key":"10.1053\/j.semdp.2020.08.002_bib0053","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2020.08.002_bib0054","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anndiagpath.2019.05.004","article-title":"TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant","volume":"41","author":"Sakhdari","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1309\/PPK0-TJUK-1UAR-3194","article-title":"Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma","volume":"115","author":"Schlette","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0056","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/4LTE-JHNC-C8RC-FGWL","article-title":"Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia","volume":"117","author":"Wong","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0057","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/AJCPF9V8XRDYWTIR","article-title":"Follicular lymphoma of the spleen: multiparameter analysis of 16 cases","volume":"131","author":"Howard","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"28","key":"10.1053\/j.semdp.2020.08.002_bib0058","doi-asserted-by":"crossref","first-page":"25061","DOI":"10.18632\/oncotarget.4677","article-title":"Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin","volume":"6","author":"Deng","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1053\/j.semdp.2020.08.002_bib0059","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0060","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3109\/10428194.2016.1154959","article-title":"A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography","volume":"57","author":"Iioka","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0061","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/1097-0142(19841201)54:11<2460::AID-CNCR2820541125>3.0.CO;2-K","article-title":"Diffuse large cell (histiocytic) lymphoma of the spleen. Clinical and pathologic characteristics of ten cases","volume":"54","author":"Harris","year":"1984","journal-title":"Cancer"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0062","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/1097-0142(19920115)69:2<413::AID-CNCR2820690223>3.0.CO;2-J","article-title":"Splenic involvement by aggressive malignant lymphomas of B-cell and T-cell types. A morphologic and immunophenotypic study","volume":"69","author":"Stroup","year":"1992","journal-title":"Cancer"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0063","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00428-008-0673-y","article-title":"Primary splenic diffuse large B-cell lymphoma manifesting in red pulp","volume":"453","author":"Kashimura","year":"2008","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1053\/j.semdp.2020.08.002_bib0064","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00000478-200307000-00004","article-title":"Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions","volume":"27","author":"Mollejo","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcp\/aqw027","article-title":"Hemophagocytosis-Related (Asian variant) intravascular large B-Cell lymphoma in a hispanic patient: a case report highlighting a micronodular pattern in the spleen","volume":"145","author":"Hall","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0066","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/modpathol.3800297","article-title":"Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases","volume":"18","author":"Morice","year":"2005","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0067","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00261-017-1454-3","article-title":"Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT","volume":"43","author":"Davidson","year":"2018","journal-title":"Abdominal Radiol"},{"issue":"13","key":"10.1053\/j.semdp.2020.08.002_bib0068","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM197609232951301","article-title":"Non-endemic Burkitts\u2019s lymphoma. A B-cell tumor related to germinal centers","volume":"295","author":"Mann","year":"1976","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0069","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0071","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1586\/era.09.91","article-title":"Clinical and biological diversity of splenic marginal zone lymphoma","volume":"9","author":"Matutes","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0072","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","article-title":"Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles","volume":"100","author":"Arcaini","year":"2004","journal-title":"Cancer"},{"issue":"7","key":"10.1053\/j.semdp.2020.08.002_bib0073","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"issue":"38","key":"10.1053\/j.semdp.2020.08.002_bib0074","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.3748\/wjg.v22.i38.8447","article-title":"Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma","volume":"22","author":"Merli","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0035-9203(97)90211-X","article-title":"Circulating villous lymphocytes\u2013a link between hyperreactive malarial splenomegaly and splenic lymphoma","volume":"91","author":"Bates","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0076","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1096-9896(199605)179:1<49::AID-PATH522>3.0.CO;2-G","article-title":"Splenic marginal zone expansion in B-cell lymphomas of gastrointestinal mucosa-associated lymphoid tissue (MALT) is reactive and does not represent homing of neoplastic lymphocytes","volume":"179","author":"Harris","year":"1996","journal-title":"J Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2020.08.002_bib0077","first-page":"1214","article-title":"Ruptured spleens with expanded marginal zones do not reveal occult B-cell clones","volume":"10","author":"Kroft","year":"1997","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0078","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.humpath.2009.09.007","article-title":"Defining the borders of splenic marginal zone lymphoma: a multiparameter study","volume":"41","author":"Dufresne","year":"2010","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0079","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2559.2009.03262.x","article-title":"Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern","volume":"54","author":"Petit","year":"2009","journal-title":"Histopathology"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.002_bib0080","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","article-title":"Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases","volume":"19","author":"Mollejo","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0081","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","article-title":"p53 abnormalities in splenic lymphoma with villous lymphocytes","volume":"97","author":"Gruszka-Westwood","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0082","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0083","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0084","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0085","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sole","year":"2001","journal-title":"Haematologica"},{"issue":"12","key":"10.1053\/j.semdp.2020.08.002_bib0086","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0087","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0088","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"10.1053\/j.semdp.2020.08.002_bib0089","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"10.1053\/j.semdp.2020.08.002_bib0091","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and Prognostication in Splenic Marginal Zone Lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0092","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.3324\/haematol.2016.161711","article-title":"Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma","volume":"102","author":"Campos-Martin","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1053\/j.semdp.2020.08.002_bib0093","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.2012.220","article-title":"Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling","volume":"26","author":"Arribas","year":"2013","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2020.08.002_bib0094","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.seminhematol.2010.01.004","article-title":"Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab","volume":"47","author":"Bennett","year":"2010","journal-title":"Semin Hematol"},{"issue":"1\u20132","key":"10.1053\/j.semdp.2020.08.002_bib0096","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2016.07.004","article-title":"Treatment of splenic marginal zone lymphoma","volume":"30","author":"Kalpadakis","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.002_bib0097","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0098","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.2008.07301.x","article-title":"High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis","volume":"143","author":"Dungarwalla","year":"2008","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.semdp.2020.08.002_bib0099","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/modpathol.3880239","article-title":"Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia","volume":"13","author":"Miranda","year":"2000","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1309\/QVJD31TEG9UJ18BQ","article-title":"Analysis of CD10+ hairy cell leukemia","volume":"120","author":"Jasionowski","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0101","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1309\/PMQXVY619Q8Y43AR","article-title":"Immunophenotypic variations in hairy cell leukemia","volume":"125","author":"Chen","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"24","key":"10.1053\/j.semdp.2020.08.002_bib0102","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1053\/j.semdp.2020.08.002_bib0103","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3324\/haematol.2011.054874","article-title":"Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders","volume":"97","author":"Blombery","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2011-08-368209","article-title":"The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms","volume":"119","author":"Arcaini","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.semdp.2020.08.002_bib0105","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","article-title":"Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation","volume":"119","author":"Xi","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0106","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"issue":"7","key":"10.1053\/j.semdp.2020.08.002_bib0107","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0108","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0109","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","article-title":"Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations","volume":"129","author":"Curiel-Olmo","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.002_bib0110","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3324\/haematol.2016.160192","article-title":"Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma","volume":"102","author":"Jallades","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0111","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","article-title":"The natural history and clinico-pathological features of the variant form of hairy cell leukemia","volume":"15","author":"Matutes","year":"2001","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"10.1053\/j.semdp.2020.08.002_bib0113","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41379-018-0093-8","article-title":"Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience","volume":"31","author":"Angelova","year":"2018","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2020.08.002_bib0114","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.leukres.2012.11.021","article-title":"Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria","volume":"37","author":"Shao","year":"2013","journal-title":"Leuk Res"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10428194.2016.1185786","article-title":"Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant","volume":"58","author":"Mason","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1053\/j.semdp.2020.08.002_bib0116","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"issue":"14","key":"10.1053\/j.semdp.2020.08.002_bib0117","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","article-title":"Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2020.08.002_bib0118","first-page":"181","article-title":"Predominance of a distinct subtype of hairy cell leukemia in Japan","volume":"7","author":"Machii","year":"1993","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.semdp.2020.08.002_bib0119","first-page":"1390","article-title":"Immunophenotypic features and configuration of immunoglobulin genes in hairy cell leukemia-Japanese variant","volume":"10","author":"Yamaguchi","year":"1996","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.semdp.2020.08.002_bib0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00428-015-1881-x","article-title":"CD27-positive hairy cell leukemia-Japanese variant","volume":"468","author":"Tabata","year":"2016","journal-title":"Virchows Arch"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:22:39Z","timestamp":1760037759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257020300691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0740257020300691"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2020.08.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell neoplasms and Hodgkin lymphoma in the spleen","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}